SCINNABIS
Science-based Medical Cannabis Products
Health Tech & Life Sciences
Non Active, Oct 2021 ceased to operate
Company Overview
Snapshot
Founded in July 2019 by Ben Peretz and Moran Mazuz, SCINNABIS operated with 1–10 employees. The company ceased operations in October 2021.
Business overview
SCINNABIS is a Health Tech & Life Sciences company focused on developing medical cannabis solutions. The company's core technology involves separating and re-integrating the active ingredients in cannabis to create personalized medicine. SCINNABIS aims to produce accurate, science-based products with specific compositions to treat various medical indications, primarily serving the pharmaceuticals sector within the healthcare and life sciences industries.
Company Intelligence Q&A
- When was SCINNABIS founded?
- SCINNABIS was founded in July 2019.
- Who are the founders of SCINNABIS?
- Ben Peretz and Moran Mazuz are the co-founders of SCINNABIS.
- What is SCINNABIS's primary focus?
- SCINNABIS focuses on developing science-based medical cannabis products by separating and re-integrating active cannabis ingredients for personalized medicine.
- What is the operational status of SCINNABIS?
- SCINNABIS ceased to operate in October 2021.
- In which sector does SCINNABIS primarily operate?
- SCINNABIS primarily operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis.